Advances in understanding N-glycosylation structure, function, and regulation in health and disease S Esmail, MF Manolson European journal of cell biology 100 (7-8), 151186, 2021 | 148 | 2021 |
Molecular mechanisms of cutis laxa–and distal renal tubular acidosis–causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4 S Esmail, N Kartner, Y Yao, JW Kim, RAF Reithmeier, MF Manolson Journal of Biological Chemistry 293 (8), 2787-2800, 2018 | 40 | 2018 |
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern C Voss, S Esmail, X Liu, MJ Knauer, S Ackloo, T Kaneko, L Lowes, ... JCI insight 6 (13), 2021 | 36 | 2021 |
Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing S Esmail, W Danter Stem cells translational medicine 10 (2), 239-250, 2021 | 29 | 2021 |
N‐linked glycosylation of a subunit isoforms is critical for vertebrate vacuolar H+‐ATPase (V‐ATPase) biosynthesis S Esmail, N Kartner, Y Yao, JW Kim, RAF Reithmeier, MF Manolson Journal of Cellular Biochemistry 119 (1), 861-875, 2018 | 24 | 2018 |
N‐Linked Glycosylation Is Required for Vacuolar H+‐ATPase (V‐ATPase) a4 Subunit Stability, Assembly, and Cell Surface Expression S Esmail, Y Yao, N Kartner, J Li, RAF Reithmeier, MF Manolson Journal of cellular biochemistry 117 (12), 2757-2768, 2016 | 18 | 2016 |
DeepNEU: artificially induced stem cell (aiPSC) and differentiated skeletal muscle cell (aiSkMC) simulations of infantile onset POMPE disease (IOPD) for potential biomarker … S Esmail, WR Danter Frontiers in cell and developmental biology 7, 325, 2019 | 16 | 2019 |
NEUBOrg: Artificially induced pluripotent stem cell-derived brain organoid to model and study genetics of Alzheimer’s disease progression S Esmail, WR Danter Frontiers in aging neuroscience 13, 643889, 2021 | 15 | 2021 |
Artificially induced pluripotent stem cell-derived whole-brain organoid for modelling the pathophysiology of metachromatic leukodystrophy and drug repurposing S Esmail, WR Danter Biomedicines 9 (4), 440, 2021 | 14 | 2021 |
Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies S Esmail, MJ Knauer, H Abdoh, C Voss, B Chin-Yee, P Stogios, A Seitova, ... Cell reports methods 1 (2), 2021 | 13 | 2021 |
Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 infectivity S Esmail, WR Danter Computational and Structural Biotechnology Journal 19, 1701-1712, 2021 | 11 | 2021 |
Expression of recombinant Streptokinase from local Egyptian Streptococcus sp. SalMarEg SA Sohaimy, E Aleem, EE Hafez, SS Esmail, M El-Saadani, NA Moneim African Journal of Biotechnology 10 (45), 9001-9011, 2011 | 8 | 2011 |
Stem‐cell based, machine learning approach for optimizing natural killer cell‐based personalized immunotherapy for high‐grade ovarian cancer S Esmail, WR Danter The FEBS Journal 289 (4), 985-998, 2022 | 5 | 2022 |
System-wide hematopoietic and immune signaling aberrations in COVID-19 revealed by deep proteome and phosphoproteome analysis T Kaneko, S Esmail, C Voss, CM Martin, M Slessarev, O Hovey, X Liu, ... medRxiv, 2021.03. 19.21253675, 2021 | 5 | 2021 |
aiCRISPRL: An Artificial Intelligence Platform for Stem Cell and Organoid Simulation with Extensive Gene Editing Capabilities WR Danter bioRxiv, 2022.06. 18.496679, 2022 | 3 | 2022 |
A novel artificial lung organoid for simulating a patient derived adenocarcinoma of lung for personalized oncology S Esmail, WR Danter medRxiv, 2021.04. 20.21255803, 2021 | 3 | 2021 |
Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants C Voss, S Esmail, X Liu, MJ Knauer, S Ackloo, T Kaneko, L Lowes, ... medRxiv, 2021.03. 16.21253716, 2021 | 3 | 2021 |
DeepNEU: a machine learning platform for simulating Cytokine Storm and Coagulopathy that complicate severe COVID-19 to enable targeted drug repurposing S Esmail, WR Danter | 2 | 2021 |
DeepNEU: a Machine Learning Stem Cell simulation platform for evaluating the impact of Loss of Function and Gain of Function mutations in the SARS-CoV-2 genome S Esmail, WR Danter | 2 | 2020 |
Rapid and accurate point-of-care testing for SARS-CoV2 antibodies S Esmail, MJ Knauer, H Abdoh, B Chin-Yee, P Stogios, A Seitova, ... medRxiv, 2020.11. 30.20241208, 2020 | | 2020 |